Skip to main content

Supplement guide

Niacin Supplements

Niacin is vitamin B3, an essential nutrient. High-dose nicotinic acid can change cholesterol levels, but major trials did not show added cardiovascular benefit when it was added to effective statin treatment. Nutritional needs, supplement forms and prescription treatment are different questions. Do not use a supplement to treat a lipid result without medical supervision.

Published by LongevityMate Editorial · Updated 2026-09-09 · 5 minute read

The short answer

Niacin Supplements explained

Niacin is vitamin B3, an essential nutrient. High-dose nicotinic acid can change cholesterol levels, but major trials did not show added cardiovascular benefit when it was added to effective statin treatment. Nutritional needs, supplement forms and prescription treatment are different questions. Do not use a supplement to treat a lipid result without medical supervision.See reference 1,See reference 2,See reference 3

On this page

The short answer

Niacin Supplements explained

Niacin is vitamin B3, an essential nutrient. High-dose nicotinic acid can change cholesterol levels, but major trials did not show added cardiovascular benefit when it was added to effective statin treatment. Nutritional needs, supplement forms and prescription treatment are different questions. Do not use a supplement to treat a lipid result without medical supervision.See reference 1,See reference 2,See reference 3

A nutrient role does not establish a high-dose benefit

Niacin helps the body make NAD and NADP, molecules used in many cellular reactions. Food, fortified products and the conversion of tryptophan contribute to niacin supply. Correcting a nutritional deficiency is different from adding a large dose to change cholesterol or pursue a longevity claim.See reference 1

Read the ingredient name, not only “B3”

Label form
Nicotinic acid
Important distinction
Can affect blood lipids at pharmacological doses and can cause flushing.See reference 1
Label form
Nicotinamide / niacinamide
Important distinction
Supplies vitamin B3 but does not have the same lipid-lowering effect or flushing profile.See reference 1
Label form
Inositol hexanicotinate / “flush-free”
Important distinction
A different preparation with variable absorption; a flush-free label does not establish equivalent clinical effects.See reference 1
Label form
Immediate, sustained or extended release
Important distinction
Release pattern matters. Do not assume products with the same milligram number are interchangeable.See reference 1,See reference 4

What the major trials tested

The trials below studied people with established cardiovascular disease who were already receiving statin-based treatment. They asked whether adding a particular niacin preparation improved clinical outcomes. They were not trials of meeting ordinary vitamin needs, treating deficiency or supplementing healthy people. The amounts are study descriptions, not instructions.See reference 2,See reference 3

Cholesterol changes and health outcomes are different

Trial and population
AIM-HIGH: 3,414 people with cardiovascular disease
Studied treatment and follow-up
Extended-release niacin 1,500–2,000 mg/day added to statin treatment; about 3 years
What it found
HDL and triglycerides improved, but there was no added benefit on the main cardiovascular outcome.See reference 2
Trial and population
HPS2-THRIVE: 25,673 people with vascular disease
Studied treatment and follow-up
Extended-release niacin 2 g plus laropiprant 40 mg/day, on statin treatment; median 3.9 years
What it found
Major vascular events occurred in 13.2% versus 13.7% with placebo; the difference was not statistically significant. Serious adverse events increased.See reference 3

What these findings do and do not establish

The HPS2-THRIVE preparation contained another medicine, laropiprant. Its harms should not all be assigned to niacin alone. AIM-HIGH tested a different regimen and also found no additional clinical benefit. Together, the trials show why a favourable change in a blood marker cannot substitute for measuring actual health outcomes.See reference 2,See reference 3

They do not prove that niacin has no medical use in any situation. They do show why adding it to an existing treatment simply to raise HDL is not justified by the HDL change alone. If you already take prescribed niacin, discuss the evidence with the prescriber rather than stopping or substituting it yourself.See reference 4

Flushing is not the only safety issue

Nicotinic acid can cause warmth, redness and itching. High supplemental or medicinal exposure can also affect liver function, glucose regulation and blood pressure. Lack of flushing does not prove safety, and high-dose nicotinamide has its own adverse effects.See reference 1

NHLBI also highlights higher blood glucose and uric acid, which can matter for diabetes or gout. Bring the exact product and a list of medicines to a pharmacist or prescriber. Release formulation and concurrent treatments affect the safety discussion.See reference 4

Before choosing or comparing a product

  • Identify the form and release pattern. “Niacin”, “niacinamide” and “no-flush” do not describe the same preparation.See reference 1,See reference 4
  • Check the amount per serving and other products containing B3. Milligrams on a study table are not a personal supplement recommendation.See reference 1
  • Clarify the goal: meeting a nutrient need or treating a condition. A clinician should assess high-dose treatment and its monitoring requirements.See reference 4

Common questions

Is niacinamide the same cholesterol treatment as nicotinic acid?

No. They are forms of vitamin B3 with different effects. Niacinamide does not have nicotinic acid’s lipid-lowering action.See reference 1

If HDL rises, has heart risk necessarily improved?

No. AIM-HIGH improved HDL and triglycerides without showing an added cardiovascular benefit over its background treatment. Marker changes and clinical outcomes must be evaluated separately.See reference 2

Does this mean I should stop prescribed niacin?

No. The trial findings do not determine an individual treatment plan. Review the reason for treatment and alternatives with your prescriber.See reference 4

References

  1. 1. Niacin: Fact Sheet for Health Professionals

    NIH Office of Dietary SupplementsOfficial guidance

  2. 2. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy

    New England Journal of MedicineRandomized trial

  3. 3. Effects of extended-release niacin with laropiprant in high-risk patients

    New England Journal of MedicineRandomized trial

  4. 4. Questions and Answers: AIM-HIGH Study

    National Heart, Lung, and Blood InstituteOfficial guidance

Editorial transparency

Published by
LongevityMate Editorial
Published
Updated

Medical disclaimer

This guide provides general education. It does not diagnose a condition, choose tests or recommend treatment or a supplement dose. Discuss your own results, symptoms and medicines with a qualified health professional.